Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2005 | 09-2004 | 09-2003 | |
| Cash Flows From Operating Activities | |||
| Net Income | 52,293 | 39,842 | 30,969 |
| Depreciation Amortization | 11,348 | 8,517 | 7,498 |
| Income taxes - deferred | -107 | -10,126 | -2,987 |
| Accounts receivable | -5,132 | -5,921 | -4,798 |
| Other Working Capital | -1,806 | 1,840 | 3,435 |
| Other Operating Activity | 23,826 | 12,706 | 5,525 |
| Operating Cash Flow | $80,422 | $46,858 | $39,642 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -14,734 | -12,522 | -6,750 |
| Net Acquisitions | -4,589 | -18,440 | -7,051 |
| Purchase Of Investment | N/A | N/A | -250 |
| Purchase Sale Intangibles | -11,789 | N/A | N/A |
| Other Investing Activity | -11,754 | 52 | 0 |
| Investing Cash Flow | $-31,077 | $-30,910 | $-14,051 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -1,292 | -1,239 | -1,397 |
| Common Stock Issued | 246,078 | 1,363 | 33 |
| Common Stock Repurchased | -72 | -144 | -38 |
| Financing Cash Flow | $244,714 | $-20 | $-1,402 |
| Exchange Rate Effect | -367 | 861 | 339 |
| Beginning Cash Position | 78,711 | 61,922 | 37,394 |
| End Cash Position | 372,403 | 78,711 | 61,922 |
| Net Cash Flow | $293,692 | $16,789 | $24,528 |
| Free Cash Flow | |||
| Operating Cash Flow | 80,422 | 46,858 | 39,642 |
| Capital Expenditure | -14,734 | -12,522 | -6,750 |
| Free Cash Flow | 65,688 | 34,336 | 32,892 |